Is it growing?
Is ASND growing?
Ascendis Pharma A/S has grown revenue 141% a year over three years and 153% a year over five.
+141%
Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +153%
Revenue growth, 5-year rate · +141% over three · growth has slowed since the five-year average
- Years of annual history on file
- 11
Years of annual history on file · FY2015 to FY2025, as filed
Details›
- Revenue FY2021
- $7.8M
- Revenue FY2022
- $51M
- Revenue FY2023
- $267M
- Revenue FY2024
- $364M
- Revenue FY2025
- $720M
Annual income statements as filed with the SEC.
Biotechnology
Ranks #59 of 145 by Smart Score